Valuation: Krka, d. d.

Market Cap 8.14B 9.28B 7.52B 6.92B 13.05B 895B 13.26B 89.92B 35.25B 438B 34.85B 34.09B 1,509B P/E 2026 *
19.6x
P/E 2027 * 18.6x
Enterprise Value 7.46B 8.51B 6.89B 6.34B 11.96B 820B 12.15B 82.4B 32.3B 401B 31.94B 31.24B 1,383B EV / Sales 2026 *
3.44x
EV / Sales 2027 * 3.23x
Free-Float
74.74%
Yield 2026 *
3.39%
Yield 2027 * 3.74%
1 day+0.93%
1 week+2.87%
Current month+7.19%
1 month+2.68%
3 months+10.04%
6 months+21.49%
Current year+32.27%
1 week 262.5
Extreme 262.5
270
1 month 249.5
Extreme 249.5
270
Current year 202
Extreme 202
270
1 year 174
Extreme 174
270
3 years 100
Extreme 100
270
5 years 80
Extreme 80
270
10 years 48.01
Extreme 48.01
270
Manager TitleAgeSince
Chief Executive Officer 70 2004-12-31
Director of Finance/CFO - 1996-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 59 2008-12-31
Director/Board Member 59 2004-12-31
Director/Board Member 59 2004-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.93%+2.87%+34.92%+137.61% 9.31B
+1.23%+1.08%+15.52%+80.84% 48.15B
-0.23%-1.65%+67.15%+109.36% 35.59B
+1.61%+0.15%-2.75%+39.18% 11.9B
+0.46%-0.16%+17.85%+89.14% 11.85B
+3.37%-0.10%+51.64%-4.77% 7.02B
-0.42%+0.25%+16.05%+34.73% 6.91B
-.--%+0.14% - - 6.79B
+0.18%-1.90%+0.63%+211.00% 6.55B
+0.13%+0.48%-31.42%+17.36% 6.13B
Average +0.73%-0.28%+18.84%+79.38% 15.02B
Weighted average by Cap. +0.71%-0.54%+27.38%+85.65%

Financials

2026 *2027 *
Net sales 2.17B 2.47B 2B 1.84B 3.47B 238B 3.53B 23.94B 9.39B 117B 9.28B 9.08B 402B 2.3B 2.62B 2.12B 1.95B 3.69B 253B 3.75B 25.41B 9.96B 124B 9.85B 9.63B 426B
Net income 420M 479M 388M 357M 673M 46.17B 684M 4.64B 1.82B 22.59B 1.8B 1.76B 77.83B 442M 504M 408M 376M 709M 48.6B 720M 4.88B 1.91B 23.78B 1.89B 1.85B 81.93B
Net Debt -680M -776M -629M -578M -1.09B -74.81B -1.11B -7.52B -2.95B -36.6B -2.91B -2.85B -126B -708M -807M -654M -602M -1.14B -77.87B -1.15B -7.82B -3.07B -38.1B -3.03B -2.97B -131B
Logo Krka, d. d.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Employees
13,204
Date Price Change Volume
26-07-16 268.50 +0.19% 2,096
26-07-20 €268.00 -0.19% 5,640
26-07-17 €268.50 +0.19% 2,096
26-07-16 €268.00 0.00% 7,778
26-07-15 €268.00 +1.13% 5,155
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
268.00EUR
Average target price
242.65EUR
Spread / Average Target
-9.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KRKG Stock